213 related articles for article (PubMed ID: 2239313)
1. Expression of vimentin and epithelial membrane antigen in human malignant lymphomas.
Sarker AB; Akagi T; Yoshino T; Hoshida Y; Takahashi K; Horie Y
Acta Pathol Jpn; 1990 Aug; 40(8):581-7. PubMed ID: 2239313
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies in the diagnosis of Hodgkin's disease. The search for a rational panel.
Chittal SM; Caverivière P; Schwarting R; Gerdes J; Al Saati T; Rigal-Huguet F; Stein H; Delsol G
Am J Surg Pathol; 1988 Jan; 12(1):9-21. PubMed ID: 2827535
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies reactive in routinely processed tissue sections of malignant lymphoma, with emphasis on T-cell lymphomas.
Strickler JG; Weiss LM; Copenhaver CM; Bindl J; McDaid R; Buck D; Warnke R
Hum Pathol; 1987 Aug; 18(8):808-14. PubMed ID: 3301626
[TBL] [Abstract][Full Text] [Related]
4. Study of vimentin expression in non-Hodgkin's lymphoma using paraffin sections.
Tamaru J; Mikata A; Itami M; Takagi T
Acta Pathol Jpn; 1990 Jul; 40(7):517-21. PubMed ID: 1699393
[TBL] [Abstract][Full Text] [Related]
5. Use of monoclonal antibodies for analyzing the distribution of the intermediate filament protein vimentin in human non-Hodgkin's lymphomas.
Giorno R; Sciotto CG
Am J Pathol; 1985 Sep; 120(3):351-5. PubMed ID: 2412444
[TBL] [Abstract][Full Text] [Related]
6. Ki-M6 immunostaining in routinely processed sections of reactive and neoplastic human lymphoid tissue.
Gloghini A; Volpe R; Carbone A
Am J Clin Pathol; 1990 Dec; 94(6):734-41. PubMed ID: 2244592
[TBL] [Abstract][Full Text] [Related]
7. Clusterin expression in malignant lymphomas: a survey of 266 cases.
Saffer H; Wahed A; Rassidakis GZ; Medeiros LJ
Mod Pathol; 2002 Nov; 15(11):1221-6. PubMed ID: 12429802
[TBL] [Abstract][Full Text] [Related]
8. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
Dorfman DM; Shahsafaei A
Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
[TBL] [Abstract][Full Text] [Related]
9. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
Miettinen M
Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
[TBL] [Abstract][Full Text] [Related]
10. Cytokeratin expression and vimentin content in large cell anaplastic lymphomas and other non-Hodgkin's lymphomas.
Gustmann C; Altmannsberger M; Osborn M; Griesser H; Feller AC
Am J Pathol; 1991 Jun; 138(6):1413-22. PubMed ID: 1711289
[TBL] [Abstract][Full Text] [Related]
11. The malignant lymphomas of Kenya: morphology, immunophenotype, and frequency of Epstein-Barr virus in 73 cases.
Cool CD; Bitter MA
Hum Pathol; 1997 Sep; 28(9):1026-33. PubMed ID: 9308726
[TBL] [Abstract][Full Text] [Related]
12. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma.
van den Berg A; Visser L; Poppema S
Am J Pathol; 1999 Jun; 154(6):1685-91. PubMed ID: 10362793
[TBL] [Abstract][Full Text] [Related]
13. Hodgkin's and non-Hodgkin's lymphoma: spectrum of morphologic and immunophenotypic overlap.
Elgin J; Phillips JG; Reddy VV; Gibbs PO; Listinsky CM
Ann Diagn Pathol; 1999 Oct; 3(5):263-75. PubMed ID: 10556472
[TBL] [Abstract][Full Text] [Related]
14. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
Nguyen PL; Harris NL; Ritz J; Robertson MJ
Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
[TBL] [Abstract][Full Text] [Related]
15. Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas. An immunocytochemical study.
Ruco LP; Pomponi D; Pigott R; Stoppacciaro A; Monardo F; Uccini S; Boraschi D; Tagliabue A; Santoni A; Dejana E
Am J Pathol; 1990 Nov; 137(5):1163-71. PubMed ID: 1700619
[TBL] [Abstract][Full Text] [Related]
16. Morphological and immunohistochemical investigation of non-Hodgkin's lymphoma combined with Hodgkin's disease.
Hansmann ML; Fellbaum C; Hui PK; Lennert K
Histopathology; 1989 Jul; 15(1):35-48. PubMed ID: 2548946
[TBL] [Abstract][Full Text] [Related]
17. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
[TBL] [Abstract][Full Text] [Related]
18. An immunocytochemical study of T-cell lymphomas using monoclonal and polyclonal antibodies effective in routinely fixed wax embedded tissues.
Norton AJ; Isaacson PG
Histopathology; 1986 Dec; 10(12):1243-60. PubMed ID: 3546052
[TBL] [Abstract][Full Text] [Related]
19. Anti-BLA.36 monoclonal antibody shows reactivity with Hodgkin's cells and B lymphocytes in frozen and paraffin-embedded tissues.
Della Croce DR; Imam A; Brynes RK; Nathwani BN; Taylor CR
Hematol Oncol; 1991; 9(2):103-14. PubMed ID: 1869241
[TBL] [Abstract][Full Text] [Related]
20. Abundance of heat shock proteins (hsp89, hsp60, and hsp27) in malignant cells of Hodgkin's disease.
Hsu PL; Hsu SM
Cancer Res; 1998 Dec; 58(23):5507-13. PubMed ID: 9850087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
